Table 1.
Pre-SMARTIE (n=117) | SMARTIE (n=117) | χ2 or t | p* | |
---|---|---|---|---|
Age, mean±SD | 81.2±7.4 | 83.3±5.7 | −2.45 | 0.015* |
Gender (Male), n(%) | 68 (58.1) | 71 (60.7) | 0.16 | 0.69 |
Screening outcomes | ||||
Cognitive deficits, n(%) | 19 (16.2) | 42 (35.9) | 11.73 | 0.001* |
Depressive symptoms, n(%) | 5 (4.3) | 18 (15.4) | 8.15 | 0.004* |
Frailty symptoms, n(%) | 6 (5.1) | 17 (14.5) | 5.73 | 0.017* |
TAVI characteristics | ||||
General anesthesia, n(%) ǂ | 116 (99.1) | 27 (23.1) | 142.4 | <0.001* |
TAVI urgency, n(%) ǂǂ | 21 (17.9) | 12 (10.3) | 2.86 | 0.09 |
Procedural outcomes | ||||
Postoperative delirium, n(%) | 16 (13.7) | 7 (6.0) | 3.91 | 0.048* |
Stroke/transient ischemic attack, n(%) | 4 (3.4) | 7 (6.0) | 0.86 | 0.35 |
Procedural complications, n(%) | 22 (18.8) | 24 (20.5) | 0.11 | 0.74 |
Hospital length of stay, mean±SD | 11.5±23.7 | 5.4±6.4 | 2.67 | 0.008* |
30-day mortality, n(%) | 9 (7.7) | 4 (3.4) | 2.04 | 0.15 |
Notes: ǂGeneral anesthesia compared to the use of local anesthesia with conscious sedation. ǂǂUrgent TAVI (including emergency and salvage surgery) compared the pre-planned procedure. *p significance: p<0.05.
Abbreviation: TAVI, transcatheter aortic valve implantation.